“…Two major G protein-coupled endocannabinoid receptors have been identified in the skin, CB1 and CB2 (Galiegue et al, 1995; Kupczyk et al, 2009; Pertwee, 2014; Stander et al, 2005; Zheng et al, 2012). Whereas binding of AEA to CB1 is involved in controlling keratinocyte growth, differentiation and apoptosis (Maccarrone et al, 2003; Paradisi et al, 2008), endocannabinoid signaling through CB2 regulates genes mediating lipid biosynthesis, immune cell signaling, cell migration and inflammation (Dobrosi et al, 2008; Kishimoto et al, 2005; Oka et al, 2006; Zheng et al, 2012). PPARα has also been identified in the skin, specifically in keratinocytes, sebaceous glands and T-cells, and it is thought to play a role in wound re-epithelialization, sebocyte differentiation, and the resolution of inflammation (Di-Poi et al, 2004; Dubrac et al, 2011; Michalik et al, 2001).…”